Effect of statins and antihyperglycemics on chronic kidney disease in patients with type 2 diabetes mellitus: a retrospective cohort study with a 12-year follow-up

Effect of statins and antihyperglycemics on chronic kidney disease in patients with type 2 diabetes mellitus: a retrospective cohort study with a 12-year follow-up

Background: Chronic Kidney Disease (CKD) represents a significant worldwide health challenge, with far-reaching implications for both patients and healthcare systems. This study aimed to identify the incidence of CKD at stages 3–5, analyzed the impact of statin and other antihyperglycemic interventi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ammar Abdulrahman Jairoun, Chong Chee Ping, Baharudin Ibrahim, Dina Farhan Al Jawamis, Asma Khaled Al Jaberi, Tasnim Dawoud, Khuloud Jamal Mohammed, Faris El-Dahiyat, Moyad Shahwan
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Journal of Pharmaceutical Policy and Practice
Subjects:	Statin Type 2 diabetes mellitus cohort study metformin diabetic nephropathy chronic kidney disease
Online Access:	https://www.tandfonline.com/doi/10.1080/20523211.2024.2414293
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
by: Paul Y. Kwo
Published: (2024-10-01)

The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
by: Izabela Szymczak-Pajor, et al.
Published: (2025-01-01)

Metformin versus insulin in glycemic control in pregnancy (MevIP): a randomized clinical trial protocol
by: Carolina Freitas Alves Amaral-Moreira, et al.
Published: (2025-02-01)

Efek Kedelai Terhadap Faal Ginjal Diabetes Melitus
by: Putri Dafriani
Published: (2011-12-01)

Metformin ameliorates peripheral neuropathy in diabetic rats by downregulating autophagy via the AMPK pathway
by: Fangqin You, et al.
Published: (2025-01-01)

Gestational Diabetes Management and Outcomes in South Jordan: Metformin Alone vs. Metformin-Insulin Therapy, A Retrospective Cohort Study
by: Ahlam M. Al-Kharabsheh, et al.
Published: (2024-11-01)

Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf
by: Alessa T, et al.
Published: (2024-12-01)

Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes
by: Lulu Sun, et al.
Published: (2025-02-01)

The state of lipid metabolism in patients with diabetic nephropathy
by: Lola Daminova, MD, PhD, DSc, et al.
Published: (2024-12-01)

Effect of cubebin against streptozotocin-induced diabetic nephropathy rats via inhibition TNF-α/NF-κB/TGF-β: in vivo and in silico study
by: Rahamat Unissa Syed, et al.
Published: (2025-02-01)

Anti-oxidative and anti-inflammatory activity of Achatina fulica mucus in streptozocin-nicotinamide-induced diabetic kidney disease: an animal model study
by: Wachid Putranto, et al.
Published: (2024-08-01)

Clinical Profile and Risk Factors for Complication of Type 2 Diabetes Mellitus at the National Referral Hospital, Bhutan: A Descriptive Cross‐Sectional Study
by: Tshering Norbu, et al.
Published: (2024-11-01)

Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study
by: Daniel J. Lee, et al.
Published: (2019-07-01)

Initiation of insulin therapy in patients with type 2 diabetes: An observational study
by: Zerovnik Spela, et al.
Published: (2022-03-01)

Statins—Their Effect on Lipoprotein(a) Levels
by: Marcin Mateusz Granat
Published: (2025-01-01)

SREBP1 induction mediates long-term statins therapy related myocardial lipid peroxidation and lipid deposition in TIIDM mice
by: Tong-sheng Huang, et al.
Published: (2024-12-01)

Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy
by: Aneta Cinakova, et al.
Published: (2025-01-01)

Steps to understanding diabetes kidney disease: a focus on metabolomics
by: Hyo Jin Kim, et al.
Published: (2024-11-01)

Correspondence on 'Is ChatGPT an Accurate and Reliable Source of Information for Patients with Vaccine and Statin Hesitancy?'
by: Hinpetch DAUNGSUPAWONG, et al.
Published: (2024-06-01)

Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database
by: Bojing Wang, et al.
Published: (2025-01-01)

Renal affection among type 2 diabetic patients and their families
by: Omar T. Selim, et al.
Published: (2023-04-01)

Karotid Endarterektomi geçiren hastalarda kontrolsüz diyabetin statin kullanan ve kullanmayan hastalarda LDL seviyelerine etkisi
by: Ateş Duman, et al.
Published: (2016-06-01)

Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome
by: Ji Soo Park, et al.
Published: (2024-12-01)

Cervical carcinoma and diabetes mellitus among women in Southern India
by: Mahima Advaith Ramakrishnan, et al.
Published: (2024-10-01)

An Overview of the Impact of Statin Therapy on Cardiac Incident Risk
by: Urszula Świrk, et al.
Published: (2025-02-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
by: John Lee, et al.
Published: (2024-12-01)

Serum Podoplanin Levels as a Potential Biomarker for Diabetic Nephropathy Progression: A Cross-Sectional Study
by: Huan F, et al.
Published: (2024-12-01)

Exacerbation of diabetes due to F. Nucleatum LPS-induced SGLT2 overexpression in the renal proximal tubular epithelial cells
by: Aiko Seki, et al.
Published: (2025-01-01)

Efficacy of valsartan combined with fermented cordyceps sinensis-4 in the treatment of diabetic nephropathy
by: Yiquan Wang, et al.
Published: (2024-12-01)

Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
by: Inha Jung, et al.
Published: (2024-11-01)

A machine learning model for predicting worsening renal function using one‐year time series data in patients with type 2 diabetes
by: Mari Watanabe, et al.
Published: (2025-01-01)

Green approach for the synthesis of zinc oxide nanoparticles from methanolic stem extract of Andrographis paniculata and evaluation of antidiabetic activity: In silico GSK-3β analysis
by: Kumar Gopal Nithesh, et al.
Published: (2025-02-01)

Statins in the practice of an internal medicine specialist: A review
by: Andrey V. Susekov
Published: (2024-11-01)

Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications
by: Moein Ebrahimi, et al.
Published: (2025-01-01)

Cellular Senescence: A Bridge Between Diabetes and Microangiopathy
by: Jiahui Liu, et al.
Published: (2024-10-01)

Metformin Reduces the Risk of Diabetic Neuropathy Among Egyptian Type 2 Diabetic Patients: A Case-Control Study
by: Yomne Hicham, et al.
Published: (2023-12-01)

Impact of duration of treatments with metformin and sulfonylureas, individually or in combination, on diabetic retinopathy among newly diagnosed type 2 diabetic patients: a pooled cohort’s analysis
by: Mansour Bahardoust, et al.
Published: (2025-01-01)

Klotho Deficiency in Severe COVID-19: A Unifying Hypothesis
by: Natalia Campos-Obando, et al.
Published: (2024-11-01)

Statin Monotherapy Not Inferior to Aspirin or Combined Aspirin and Statins Reducing the Incidences of Cirrhosis, HCC, and Mortality in MAFLD/MASH Patients: A Population Cohort Study
by: Lee CH, et al.
Published: (2024-12-01)

Correction: Exploring the knowledge, attitude and practice towards disaster medicine preparedness and readiness: A prescriptive insight by the community pharmacists in the United Arab Emirates.
by: Ammar Abdulrahman Jairoun, et al.
Published: (2024-01-01)